医学
前列腺癌
限制
疾病
癌症检测
疾病监测
癌症
前列腺
肿瘤科
重症监护医学
内科学
机械工程
工程类
作者
Peter R. Carroll,J. Kellogg Parsons,Gerald L. Andriole,Robert R. Bahnson,Daniel A. Barocas,Erik P. Castle,William J. Catàlona,Douglas M. Dahl,John W. Davis,Jonathan I. Epstein,Ruth Etzioni,Thomas Farrington,George P. Hemstreet,Mark H. Kawachi,Paul H. Lange,Kevin R. Loughlin,William T. Lowrance,Paul Maroni,James L. Mohler,Todd M. Morgan
出处
期刊:Journal of The National Comprehensive Cancer Network
日期:2015-12-01
卷期号:13 (12): 1534-1561
被引量:67
标识
DOI:10.6004/jnccn.2015.0181
摘要
Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI